Aug 2026· Neurology, neuropsychiatry, Psychosomatics· 0 citations· 15 references
TL;DR
Four clinical cases of NMOSD that illustrate the difficulties in making a timely diagnosis due to an ambiguous clinical, radiological and laboratory picture were presented and strategies to improve the early diagnosis of NMOSD to prevent such outcomes were proposed.
Abstract
Neuromyelitis optica spectrum disorders (NMOSD) constitute a group of rare, autoimmune and often disabling diseases of the central nervous system. Despite clear diagnostic criteria for NMOSD, diagnostic errors remain a serious problem, leading to delays in necessary treatment and adverse outcomes. This article presents four clinical cases of NMOSD that illustrate the difficulties in making a timely diagnosis due to an ambiguous clinical, radiological and laboratory picture. In these cases, clinical manifestations typical of NMOSD (optic neuritis, acute myelitis and area postrema syndrome) are described; however, the patients were initially referred to specialists in other fields: ophthalmologists, gastroenterologists and neurosurgeons, which led to a delay in their referral to the Multiple Sclerosis Centre and a late diagnosis. The delayed initiation of pathogenetic therapy in two patients led to the development of persistent severe disability as a consequence of NMOSD exacerbations. Factors contributing to the prolonged time to diagnosis were analyzed, and strategies to improve the early diagnosis of NMOSD to prevent such outcomes were proposed.
The clinical patterns of acute attacks and relapses of multiple sclerosis, NMOSD and MOGAD are discussed, including the clinical and para-clinical modalities that are critical for timely recognition and diagnosis, and available evidence regarding treatment selection and responsiveness is presented.
Yu-Jing Li, Wei Jiang, Chao Zhang et al.· Cell Death and Differentiati...· 0 citations
Age at diagnosis may represent a relevant clinical factor when evaluating disability burden in NMOSD and further prospective multicenter studies are warranted to better define longitudinal outcomes and prognostic factors in LO-NMOSD.
O. Mirmosayyeb, Mehra Fekri, Mohammad Yazdan Panah et al.· Acta Neurologica Belgica· 0 citations
Osmotic demyelinating syndrome (ODS) is a rare disorder that occurs when the osmotic pressure of the blood changes rapidly and leads to serious neurological disorders.
Purpose
: to conduct a review of literary sources of domestic and foreign authors examining ODS, and also to describe it using the example of our ow...
A. Raevskaya, O. Kovaleva, D. Zinchenko et al.· Russian neurological Journal· 0 citations
Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system that predominantly affects women of reproductive age. Pregnancy requires careful pharmacological decision-making because maternal relapse can lead to severe neurological disability, while fetal expo...
Chun-Fei Wang, Yu-Fei Zhang, Q. Wei et al.· Frontiers in Pharmacology· 0 citations
Introduction: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder frequently complicated by plexiform neurofibromas (PN), which cause severe functional impairment and present a complex therapeutic challenge. Methods: This descriptive case series evaluates four pediatric patients diagnosed with NF1 and prog...